Kymab
- Date:
- 2010-2015
- Reference:
- PBL/BIO/A/12
- Part of:
- Biotechnology company grey literature
- Archives and manuscripts
About this work
Description
Series contains digital versions of news articles and press releases collected from Kymab in 2015.
Publication/Creation
2010-2015
Physical description
35 document files, 2 other files 217.9 MB (2179190 bytes)
Biographical note
Kymab discovers and develops fully human monoclonal antibody therapeutics, employing proprietary technologies including KymouseTM, a pioneering transgenic mouse platform. Kymab was incorpoated in 2009 and has since raised over $70 million in equity from The Wellcome Trust and The Bill and Melinda Gates Foundation. More information can be found at www.kymab.com.
Where to find it
Location Status Access Closed storesBy appointment Manual request